• #15 - Dr. Sharon Lewin: HIV/AIDS Overview, Finding a Cure, and Improving Treatment

  • May 20 2024
  • Length: 43 mins
  • Podcast

#15 - Dr. Sharon Lewin: HIV/AIDS Overview, Finding a Cure, and Improving Treatment

Listen for free

View show details

  • Summary

  • Dr. Sharon Lewin is the President of the International AIDS Society and the Director of the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia. As a physician and researcher, Sharon has studied HIV for over 25 years.

    In this episode, I learn about the science, history, and treatment of HIV. Sharon provides insights into the future of HIV treatment and what finding a cure might look like. We also discuss innovation, the role of AI and bioengineering, and their potential impact on a global scale.

    Timestamps:

    (00:00) Episode Introduction

    (01:19) What is HIV/AIDS?

    (03:55) Progression of HIV

    (06:22) Antiretroviral Therapy (ART)

    (08:10) Medical Response in the 80s/90s

    (11:38) Conspiracies

    (12:28) Cont. Medical Response

    (13:22) Stigma and Societal Responses

    (17:56) Curing/Treating HIV

    (25:09) New and Exciting Research

    (29:49) HIV Treatment in 10 Years

    (32:13) Public Health Initiatives for HIV

    (34:29) Bioengineering, Computer Science, and AI

    (38:49) Global Impact and Response

    (41:25) Outro

    Contact us here.

    Linktree: linktr.ee/gustavofrancopod
    Show More Show Less
Show More Show Less

What listeners say about #15 - Dr. Sharon Lewin: HIV/AIDS Overview, Finding a Cure, and Improving Treatment

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.